Curative propensity of green tea extract towards hepatic fibrosis induced by CCL 4: A histopathological study

Experimental and Therapeutic Medicine

Volumn 3, Issue 5, 2012, Pages 781-786

  Safer, A M ^a   Afzal, M ^a   Nomani, A ^a   Sosamma, O ^a   Mousa, S A ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Alanine aminotranferase; Aspartate aminotransferase; Carbon tetrachloride; Collagen fibers; Extracellular matrix; Green tea extract; Scanning electron microscopy

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; FAT DROPLET; GREEN TEA EXTRACT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOPSY; BODY WEIGHT; CONTROLLED STUDY; DISEASE SEVERITY; HISTOPATHOLOGY; LIVER; LIVER FIBROSIS; LIVER PROTECTION; LYOPHILISATE; MALE; NONHUMAN; PLANT LEAF; RAT; SCANNING ELECTRON MICROSCOPY; TREATMENT DURATION; WEIGHT REDUCTION;

EID: 84858672077     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.503     Document Type: Article

References (32)

1. Paz Z and Shoenfeld Y: Anti-fibrosis: to reverse the irreversible. Clin Rev Allergy Immunol 38: 276-286, 2010.
2. Bateller R and Brenner DA: Liver fibrosis. J Clin Invest 115: 209-218, 2005.
3. Bissell DM: Hepatic fibrosis as wound repair: a progress report. J Gastroenterol 33: 295-302, 1998.
4. Kim HK, Yang TH and Cho HY: Antifibrotic effects of green tea on in vitro and in vivo models of liver fibrosis. World J Gastroenterol 15: 5200-5205, 2009.
5. Li CH, Piao DM, Xu WX, Yin ZR, Jin JS and Shen ZS: Morphological and serum hyaluronic acid, laminin and type IV collagen changes in dimethylnitrosamine-induced hepatic fibrosis of rats. World J Gastroenterol 28: 7620-7624, 2005.
6. Wu J and Zern MA: Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol 35: 665-672, 2000.
7. Al-Bloushi S, Safer AM, Afzal M and Shaker M: Green tea modulates reserpine toxicity in animal model. J Toxicol Sci 34: 77-87, 2009.
8. Safer AM, Afzal M, Al-Bloushi S, Rafique M and Mousa SA: Inhibition property of green tea extract in relation to reserpine-induced ribosomal strips of rough endoplasmic reticulum (rER) of the rat kidney proximal tubule cells. J Toxicol Sci 34: 637-645, 2009.
9. Wang XH, Zhao J, Zhang W, Zhang L, Ma R, Wang L, Zhang S and Tian L: Scanning electron microscopic observation: three-dimensional architecture of the collagen in hepatic fibrosis rats. Chin Med J 120: 308-312, 2007.
10. Borrelli F, Capasso R, Russo A and Ernst E: Systematic review: green tea and gastrointestinal cancer risk. Aliment Pharmacol Ther 19: 497-510, 2004.
11. Cooper R, Morre DJ and Morre DM: Medicinal benefits of green tea: part I. Review of non-cancer health benefits. J Altern Complement Med 11: 521-528, 2005.
12. Fujita H and Yamagami T: Anti-hypercholesterolemia effect of Chinese black tea extract in human subjects with borderline hypercholesterolemia. Nutr Res 28: 450-456, 2008.
13. Gross G, Meyer KG, Pres H, Thielert C, Tawfik H and Mescheder A: A randomized, double-blind, four-arm parallel-group, placebo-controlled Phase II/III study to investigate the clinical efficacy of two galenic formulations of Polyphenon E in the treatment of external genital warts. J Eur Acad Dermatol Venereol 2: 1404-1412, 2007.
14. Inoue M, Tajima K and Mizutani M: Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett 167: 175-182, 2001.
15. Jian L, Xie LP, Lee AH and Binns CW: Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int J Cancer 108: 130-135, 2004.
16. Jin X, Zheng RH and Li YM: Green tea consumption and liver disease: a systematic review. Liver Int 28: 990-996, 2008.
17. Kato A, Minoshima Y, Yamamoto J, Adachi I, Watson AA and Nash RJ: Protective effects of dietary chamomile tea on diabetic complications. J Agric Food Chem 56: 8206-8211, 2008.
18. Kovacs EM, Lejeune MP, Nijs I and Westerterp-Plantenga MS: Effects of green tea on weight maintenance after body-weight loss. Br J Nutr 91: 431-437, 2004.
19. Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y and Tsuji I: Green tea consumption and mortality due to cardiovascular disease, cancer and all causes in Japan: the Ohsaki study. JAMA 296: 1255-1265, 2006.
20. Low Dog T, Riley D and Carter T: Traditional and alternative therapies for breast cancer. Altern Ther Health Med 7: 36-47, 2001.
21. Lyn-Cook BD, Rogers T, Yan Y, Blann EB, Kadlubar FF and Hammons GJ: Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro. Nutr Cancer 35: 80-86, 1999.
22. Inoue M, Sasazuki S, Wakai K, Suzuki T, Matsuo K, Shimazu T, Tsuji I, Tanaka K, Mizoue T, Nagata C, et al: Green tea consumption and gastric cancer in Japanese: a pooled analysis of six cohort studies. Gut 58: 1323-1332, 2009.
23. Miura Y, Chiba T, Tomita I, Koizumi H, Miura S, Umeqaki K, Hara Y, Ikeda M and Tomita T: Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr 131: 27-32, 2001.
24. Nagao T, Hase T and Tokimitsu I: A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring) 15: 1473-1483, 2007.
25. Lotersztajn S, Julien B, Teixeira-Clerc F, Grenard P and Mallat A: Hepatic fibrosis molecular mechanisms and drug targets (Review). Annu Rev Pharmacol Toxicol 45: 605-628, 2005.
26. Gressner AM: The cell biology of liver fibrogenesis - an imbalance of proliferation, growth arrest and apoptosis of myofibroblasts. Cell Tissue Res 292: 447-452, 1998.
27. Oh SW, Kim DH, Ha JR and Kim DY: Anti-fibrotic effects of a methylenedioxybenzene compound, CW209292 on dimethylnitrosamine-induced hepatic fibrosis in rats. Biol Pharm Bull 32: 1364-1370, 2009.
28. Yang CS: Tea and health. Nutrition 15: 946-949, 1999.
29. Ohta Y, Kongo M, Sasaki E, Nishida K and Ishiguro I: Therapeutic effect of melatonin on carbon tetrachloride-induced acute liver injury in rats. J Pineal Res 28: 119-126, 2000.
30. Salah N, Miller NJ, Paganga G, Tijburg L, Bolwell GP and Rice-Evans C: Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch Biochem Biophys 322: 339-346, 1995.
31. Gouni-Berthold I and Sachinidis A: Molecular mechanisms explaining the preventive effects of catechins on the development of proliferative diseases. Curr Pharm Des 10: 1261-1271, 2004.
32. Mandel S and Youdim MB: Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic Biol Med 37: 304-317, 2004.